Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia

scientific article

Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1038988899
P356DOI10.1038/LEU.2012.125
P932PMC publication ID3437408
P698PubMed publication ID22948489
P5875ResearchGate publication ID230797413

P50authorM. Carmen ChillónQ73432002
Alberto OrfaoQ89543246
Paulo LucioQ51040096
Tomáš KalinaQ56461250
Jacques Van DongenQ60655923
Łukasz SędekQ60659028
P2093author name stringP Evans
E Sonneveld
V H J van der Velden
T Szczepański
M Kneba
S Böttcher
N Boeckx
J Almeida
W M Comans-Bitter
M Cullen
A Mendonça
A Koning
P M Vermeulen
J Flores-Montero
EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708)
H Wai
R Varro
E P Dixon
A L Noordijk
E H A Dekking
M T de Man
N Van Poecke
P Hoogeveen
V Kanderová
P2860cites workThe signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemiaQ78109251
The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusionQ28273363
Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemiaQ30982911
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.Q31012437
How I treat acute promyelocytic leukemiaQ33508071
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemiaQ33797115
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics [...]Q34002951
Translocations of the RARalpha gene in acute promyelocytic leukemiaQ34435522
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNetQ34597535
Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.Q34977308
Morphological and cytochemical characteristics of leukaemic promyelocytesQ35205488
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.Q35561038
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemiaQ36276965
The coagulopathy of acute promyelocytic leukaemia revisitedQ37414607
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.Q39661216
Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemiaQ40917700
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).Q41081871
NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).Q41692539
FIP1L1/RARA with breakpoint at FIP1L1 intron 13: a variant translocation in acute promyelocytic leukemiaQ42930429
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.Q45977750
The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.Q46008058
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.Q52528247
Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.Q52533879
The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.Q52581361
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.Q54441361
Rapid Diagnosis of Acute Promyelocytic Leukemia by Analyzing the Immunocytochemical Pattern of the PML Protein With the Monoclonal Antibody PG-M3Q57279652
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectacute promyelocytic leukemiaQ612108
flow cytometryQ1141429
P304page(s)1976-1985
P577publication date2012-05-08
P1433published inLeukemiaQ6534498
P1476titleFlow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia
P478volume26

Reverse relations

cites work (P2860)
Q90262439"Immuno-flowFISH" for the Assessment of Cytogenetic Abnormalities in Chronic Lymphocytic Leukemia
Q53296637Acute Myelogenous Leukemia with Cuplike Nuclei.
Q38890974Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia
Q24605023EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine
Q33889952Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia
Q35674595Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques
Q38731027Fusion genes in malignant neoplastic disorders of haematopoietic system
Q38801669High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells
Q37155342Measurement of Soluble Biomarkers by Flow Cytometry
Q49029848Measurement of lymphocyte aggregation by flow cytometry-physiological implications in chronic lymphocytic leukemia
Q38677257Proteogenomics for understanding oncology: recent advances and future prospects
Q48230365Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL).

Search more.